67 related articles for article (PubMed ID: 25715577)
1. [Microbial translocation in HIV infection].
Oleksiuk J; Grzeszczuk A
Pol Merkur Lekarski; 2014 Dec; 37(222):353-5. PubMed ID: 25715577
[TBL] [Abstract][Full Text] [Related]
2. Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections.
Nowroozalizadeh S; Månsson F; da Silva Z; Repits J; Dabo B; Pereira C; Biague A; Albert J; Nielsen J; Aaby P; Fenyö EM; Norrgren H; Holmgren B; Jansson M
J Infect Dis; 2010 Apr; 201(8):1150-4. PubMed ID: 20199244
[TBL] [Abstract][Full Text] [Related]
3. Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy.
Marchetti G; Bellistrì GM; Borghi E; Tincati C; Ferramosca S; La Francesca M; Morace G; Gori A; Monforte AD
AIDS; 2008 Oct; 22(15):2035-8. PubMed ID: 18784466
[TBL] [Abstract][Full Text] [Related]
4. Microbial Translocation Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults With Suppressed Viremia.
Younas M; Psomas C; Reynes C; Cezar R; Kundura L; Portales P; Merle C; Atoui N; Fernandez C; Le Moing V; Barbuat C; Moranne O; Sotto A; Sabatier R; Fabbro P; Vincent T; Dunyach-Remy C; Winter A; Reynes J; Lavigne JP; Corbeau P
Front Immunol; 2019; 10():2185. PubMed ID: 31572392
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.
Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A
J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290
[TBL] [Abstract][Full Text] [Related]
6. Microbial translocation: a marker of advanced HIV-1 infection and a predictor of treatment failure?
Cassol E; Rossouw T; Seebregts C; Cassol S
J Infect Dis; 2011 Mar; 203(5):747-8. PubMed ID: 21278212
[No Abstract] [Full Text] [Related]
7. Microbial translocation, immune activation, and HIV disease.
Klatt NR; Funderburg NT; Brenchley JM
Trends Microbiol; 2013 Jan; 21(1):6-13. PubMed ID: 23062765
[TBL] [Abstract][Full Text] [Related]
8. Immune Activation and Bacterial Translocation: A Link between Impaired Immune Recovery and Frequent Visceral Leishmaniasis Relapses in HIV-Infected Patients.
Silva-Freitas ML; Cota GF; Machado-de-Assis TS; Giacoia-Gripp C; Rabello A; Da-Cruz AM; Santos-Oliveira JR
PLoS One; 2016; 11(12):e0167512. PubMed ID: 27907136
[TBL] [Abstract][Full Text] [Related]
9. Effect of cytomegalovirus-induced immune response, self antigen-induced immune response, and microbial translocation on chronic immune activation in successfully treated HIV type 1-infected patients: the ANRS CO3 Aquitaine Cohort.
Wittkop L; Bitard J; Lazaro E; Neau D; Bonnet F; Mercie P; Dupon M; Hessamfar M; Ventura M; Malvy D; Dabis F; Pellegrin JL; Moreau JF; Thiébaut R; Pellegrin I;
J Infect Dis; 2013 Feb; 207(4):622-7. PubMed ID: 23204178
[TBL] [Abstract][Full Text] [Related]
10. Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy.
Cassol E; Malfeld S; Mahasha P; van der Merwe S; Cassol S; Seebregts C; Alfano M; Poli G; Rossouw T
J Infect Dis; 2010 Sep; 202(5):723-33. PubMed ID: 20629534
[TBL] [Abstract][Full Text] [Related]
11. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
12. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
13. Characterization of immunologic and virological parameters in HIV-infected patients with primary effusion lymphoma during antiblastic therapy and highly active antiretroviral therapy.
Simonelli C; Tedeschi R; Gloghini A; Bortolin MT; Spina M; Bidoli E; Cinelli R; De Paoli P; Carbone A; Tirelli U
Clin Infect Dis; 2005 Apr; 40(7):1022-7. PubMed ID: 15824995
[TBL] [Abstract][Full Text] [Related]
14. [HIV infection and chronic inflammation: is the bacterial translocation the underlying cause?].
Estébanez-Muñoz M; Stella N; Bernardino JI
Med Clin (Barc); 2012 May; 138(15):673-7. PubMed ID: 22364956
[TBL] [Abstract][Full Text] [Related]
15. Microbial translocation and T cell activation are not associated in chronic HIV-infected children.
Madrid L; Noguera-Julian A; Falcon-Neyra L; Fortuny C; De Felipe B; Torrebadell M; Sanchez B; Valls A; López-Cortès L; Benmarzouk-Hidalgo OJ; Neth O
AIDS; 2014 Aug; 28(13):1989-92. PubMed ID: 25259707
[TBL] [Abstract][Full Text] [Related]
16. HIV persistence in the gut mucosa of HIV-infected subjects undergoing antiretroviral therapy correlates with immune activation and increased levels of LPS.
d'Ettorre G; Paiardini M; Zaffiri L; Andreotti M; Ceccarelli G; Rizza C; Indinnimeo M; Vella S; Mastroianni CM; Silvestri G; Vullo V
Curr HIV Res; 2011 Apr; 9(3):148-53. PubMed ID: 21457131
[TBL] [Abstract][Full Text] [Related]
17. Microbial translocation is a cause of systemic immune activation in chronic HIV infection.
Brenchley JM; Price DA; Schacker TW; Asher TE; Silvestri G; Rao S; Kazzaz Z; Bornstein E; Lambotte O; Altmann D; Blazar BR; Rodriguez B; Teixeira-Johnson L; Landay A; Martin JN; Hecht FM; Picker LJ; Lederman MM; Deeks SG; Douek DC
Nat Med; 2006 Dec; 12(12):1365-71. PubMed ID: 17115046
[TBL] [Abstract][Full Text] [Related]
18. Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy.
Chege D; Sheth PM; Kain T; Kim CJ; Kovacs C; Loutfy M; Halpenny R; Kandel G; Chun TW; Ostrowski M; Kaul R;
AIDS; 2011 Mar; 25(6):741-9. PubMed ID: 21378536
[TBL] [Abstract][Full Text] [Related]
19. Elevated plasma levels of lipopolysaccharide and high mobility group box-1 protein are associated with high viral load in HIV-1 infection: reduction by 2-year antiretroviral therapy.
Trøseid M; Nowak P; Nyström J; Lindkvist A; Abdurahman S; Sönnerborg A
AIDS; 2010 Jul; 24(11):1733-7. PubMed ID: 20502315
[TBL] [Abstract][Full Text] [Related]
20. Immune activation and increased IL-21R expression are associated with the loss of memory B cells during HIV-1 infection.
Ruffin N; Lantto R; Pensieroso S; Sammicheli S; Hejdeman B; Rethi B; Chiodi F
J Intern Med; 2012 Nov; 272(5):492-503. PubMed ID: 22530560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
